Moderna Inc.
MRNA | NASDAQ
$183.28
+$10.34 (+5.98%)
Sep 22, 2026, 10:58 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -3.15B | -3.19B | -2.82B | -3.12B | -2.9B | -3.36B | -3.56B | -2.22B | -5.87B | -5.97B | -4.71B | -3.47B | 1.21B | 4.78B | 8.36B | 11.77B | 14.06B | 14.64B | 12.2B | 7.06B | 3.49B | 598.17M |
Depreciation & Amortization | 174M | 168M | 148M | 208M | 208M | 192M | 189M | 331M | 528M | 579M | 621M | 499M | 363M | 347M | 348M | 346M | 303M | 296M | 232M | 161.71M | 100.21M | 39.21M |
Stock-Based Compensation | 349M | 359M | 370M | 474M | 461M | 443M | 429M | 404M | 369M | 331M | 305M | 288M | 281M | 257M | 226M | 201M | 171M | 156M | 142M | 130.48M | 113.69M | 103.69M |
Other Working Capital | 717M | 1.1B | 224M | -90M | 1.12B | 1.16B | 1.19B | -48M | -41M | -176M | -1.39B | -2.8B | -5.1B | -7.14B | -5.98B | -4.68B | -2.49B | -104M | 4.28B | 8.05B | 8.01B | 7.97B |
Other Non-Cash Items | 814M | 204M | 198M | 45M | -1.78B | -1.8B | -1.8B | -1.86B | 26M | -27M | -19M | -12M | -43M | 38M | 59M | 92M | 68M | 50M | 37M | 83.37M | 83.54M | 75.58M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -106M | 1.36B | 1.14B | 828M | 848M | -713M | -723M | -559M | -702M | -605M | -397M | -301M | -72M | -72M | -50M |
Change in Working Capital | 762M | 1.02B | 254M | 411M | 1.32B | 1.47B | 1.74B | 249M | 345M | 1.07B | -139M | -235M | -1.32B | -3.71B | -3.46B | -5.07B | -4.34B | -1.33B | 1.31B | 4.21B | 5.47B | 4.34B |
Operating Cash Flow | -1.05B | -1.45B | -1.85B | -1.98B | -2.7B | -3.05B | -3B | -3.21B | -3.24B | -2.88B | -3.12B | -2.08B | -226M | 993M | 4.98B | 6.63B | 9.65B | 13.41B | 13.62B | 11.57B | 9.19B | 5.1B |
Capital Expenditures | -171M | -137M | -202M | -685M | -803M | -982M | -1.05B | -749M | -738M | -790M | -707M | -579M | -528M | -381M | -400M | -428M | -438M | -381M | -284M | -187.3M | -107.59M | -96.23M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -85M | -85M | -85M | -85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -4.61B | -5.35B | -5.77B | -6.11B | -6.2B | -5.75B | -6.53B | -6.3B | -5.87B | -5.22B | -3.78B | -4.63B | -4.01B | -6.97B | -11.44B | -11.3B | -14.83B | -17.5B | -12.65B | -10.91B | -8.61B | -3.06B |
Sales Maturities Of Investments | 5.69B | 6.63B | 7.92B | 8.25B | 8.48B | 9.29B | 9.53B | 9B | 8.63B | 8.32B | 8.78B | 9B | 8.48B | 8.2B | 6.7B | 6.53B | 5.79B | 5.68B | 4.44B | 3.52B | 3.29B | 1.62B |
Other Investing Acitivies | n/a | n/a | -10M | -10M | -10M | -10M | n/a | n/a | n/a | n/a | n/a | -5M | -5M | -5M | -40M | -65M | -65M | -65M | -30M | n/a | n/a | 521K |
Investing Cash Flow | 905M | 1.14B | 1.95B | 1.46B | 1.48B | 2.56B | 1.95B | 1.95B | 2.02B | 2.31B | 4.21B | 3.7B | 3.85B | 756M | -5.18B | -5.27B | -9.54B | -12.26B | -8.52B | -7.58B | -5.43B | -1.54B |
Debt Repayment | 542M | 537M | 539M | -20M | -14M | -7M | -10M | -120M | -188M | -246M | -270M | -207M | -188M | -178M | -184M | -167M | -155M | -169M | -140M | -102.25M | -68.26M | -8.22M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | -627M | -1.15B | -1.56B | -2.56B | -3.23B | -3.33B | -3.78B | -2.78B | -1.48B | -857M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.04M | -7.04M | -7.04M |
Other Financial Acitivies | 11M | -3M | -2M | -1M | -1M | -1M | n/a | n/a | n/a | 16M | 16M | 16M | 16M | n/a | n/a | n/a | n/a | n/a | n/a | 7.04M | 7.31M | 7.07M |
Financial Cash Flow | 590M | 585M | 572M | 9M | 21M | 46M | 56M | -50M | -119M | -821M | -1.38B | -1.71B | -2.69B | -3.35B | -3.45B | -3.88B | -2.84B | -1.54B | -873M | 44.11M | 76.11M | 1.48B |
Net Cash Flow | 442M | 282M | 667M | -513M | -1.2B | -445M | -999M | -1.31B | -1.34B | -1.39B | -289M | -88M | 937M | -1.6B | -3.64B | -2.52B | -2.73B | -393M | 4.22B | 4.04B | 3.84B | 5.05B |
Free Cash Flow | -1.22B | -1.58B | -2.05B | -2.66B | -3.5B | -4.03B | -4.06B | -3.96B | -3.98B | -3.67B | -3.83B | -2.66B | -754M | 612M | 4.58B | 6.2B | 9.22B | 13.03B | 13.34B | 11.39B | 9.08B | 5.01B |
Adj. Free Cash Flow | -1.57B | -1.94B | -2.42B | -3.14B | -3.96B | -4.48B | -4.48B | -4.36B | -4.35B | -4B | -4.13B | -2.95B | -1.04B | 355M | 4.36B | 6B | 9.04B | 12.88B | 13.19B | 11.26B | 8.97B | 4.9B |
Maintenance CapEx | -168M | -134M | -202M | -685M | -797.95M | -976.95M | -1.05B | -743.95M | -738M | -790M | -707M | -579M | -528M | -338.16M | -225.16M | -133.16M | -44.16M | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -3M | -3M | n/a | n/a | -5.05M | -5.05M | -5.05M | -5.05M | n/a | n/a | n/a | n/a | n/a | -42.84M | -174.84M | -294.84M | -393.84M | -381M | -284M | -187.3M | -107.59M | -96.23M |
Owner Earnings | -1.22B | -1.58B | -2.05B | -2.66B | -3.49B | -4.03B | -4.05B | -3.95B | -3.98B | -3.67B | -3.83B | -2.66B | -754M | 654.84M | 4.76B | 6.5B | 9.61B | 13.41B | 13.62B | 11.57B | 9.19B | 5.1B |
Add to Watchlist
Select watchlists to add or remove MRNA